|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
ERP44, ng/mL
|
10
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0
|
|
ERP44, OD.
|
2.416
|
1.342
|
0.746
|
0.414
|
0.23
|
0.128
|
0.071
|
0.047
|
|
Hsp-20, ng/mL
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0.078
|
0
|
|
Hsp-20, OD.
|
3.441
|
1.912
|
1.062
|
0.59
|
0.328
|
0.182
|
0.101
|
0.067
|
|
HSP-27, ng/mL
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0.078
|
0
|
|
HSP-27, OD.
|
2.673
|
1.485
|
0.825
|
0.458
|
0.255
|
0.141
|
0.079
|
0.052
|
|
Hsp-40, ng/mL
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0.078
|
0
|
|
Hsp-40, OD.
|
2.622
|
1.457
|
0.809
|
0.45
|
0.25
|
0.139
|
0.077
|
0.051
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Human ERP44, Hsp-20, HSP-27, Hsp-40 and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
80-90
|
85
|
|
EDTA plasma(n=5)
|
87-95
|
91
|
|
Cell Culture Media(n=5)
|
90-108
|
99
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6.2
|
6.8
|
6.4
|
8.2
|
8.9
|
7.7
|